AI-Driven Antigen Design Meets Synthetic Biology for Universal mRNA Vaccines

Zhao & Zai (2025) note that AI is improving antigen design, while Pfeifer et al. (2023) highlight synthetic biology’s role in augmenting RNA therapeutics. However, what if we take this a step further and create mRNA vaccine constructs that “self-update” or can be rapidly re-coded based on real-time AI surveillance of viral mutations? For example, an mRNA vaccine could encode not only canonical viral antigens but also a synthetic regulatory circuit that senses host immune responses and modulates antigen expression accordingly, or even includes “plug-and-play” regions for rapid antigen swapping. This would move beyond static vaccine design toward a platform that’s as dynamic as the pathogens it combats—potentially enabling truly universal influenza, coronavirus, or even pan-respiratory mRNA vaccines that are robust to antigenic drift and shift. This approach fuses the strengths of AI (rapid, predictive design) and synthetic biology (programmable, modular constructs)—a combination not yet realized in current literature.

References:

1. Proceeding artificial intelligence technology towards vaccine designs. Fangxin Zhao, Xiaodong Zai (2025). The Innovation Life.
2. Harnessing synthetic biology for advancing RNA therapeutics and vaccine design. B. Pfeifer, M. Beitelshees, A. Hill, Justin Bassett, Charles H. Jones (2023). npj Systems Biology and Applications.